2015
DOI: 10.1097/mol.0000000000000212
|View full text |Cite
|
Sign up to set email alerts
|

Immune-mediated and lipid-mediated platelet function in atherosclerosis

Abstract: A better understanding of the molecular mechanisms of platelet-related immune activity allows their utilization as powerful diagnostic tools or targets of therapeutic intervention. Those findings might help to develop new classes of drugs which may supplement or replace classical anticoagulants and help clinicians to tackle CVD more efficiently.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 196 publications
(133 reference statements)
0
12
0
Order By: Relevance
“…Moreover, these values were within the normal range according to respected values [ 28 , 29 ]. It is already known that platelets express and secrete inflammatory mediators (chemokines, sp-selectin, interleukin-1β, thromboxane, cytokines) and that elevated platelet counts were related to poor cardiovascular clinical outcomes [ 30 33 ]. The differences between groups and sequential changes in the platelet count and the mean platelet volume are summarized in Table 2 .…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, these values were within the normal range according to respected values [ 28 , 29 ]. It is already known that platelets express and secrete inflammatory mediators (chemokines, sp-selectin, interleukin-1β, thromboxane, cytokines) and that elevated platelet counts were related to poor cardiovascular clinical outcomes [ 30 33 ]. The differences between groups and sequential changes in the platelet count and the mean platelet volume are summarized in Table 2 .…”
Section: Resultsmentioning
confidence: 99%
“…86 Reducing cholesterol and circulating LDL levels affects platelet reactivity by cholesterol-dependent and pleiotropic, cholesterol-independent effects. 87 Clinically, pleiotropic, antithrombotic actions of statins have been concluded from the JUPITER trial that showed a significant reduction of deep vein thrombosis in the cohort treated with rosuvastatin. 88 Which molecular mechanisms lie behind these assumed antiplatelet effects have been investigated in preclinical studies.…”
Section: Sphingolipidsmentioning
confidence: 99%
“…22 Platelet biology has been implicated in lipid metabolism and atherosclerosis, suggesting rs895953 could be affecting CAD risk through platelet-related pathways. 35,36…”
Section: Locus Associated With Tg and Hdl-c May Regulate Genes Affectmentioning
confidence: 99%